PL3548001T3 - Sposób wytwarzania roztworu nanocząstek kwasu acetylosalicylowego albo diosminy albo drotaweryny - Google Patents

Sposób wytwarzania roztworu nanocząstek kwasu acetylosalicylowego albo diosminy albo drotaweryny

Info

Publication number
PL3548001T3
PL3548001T3 PL16816395T PL16816395T PL3548001T3 PL 3548001 T3 PL3548001 T3 PL 3548001T3 PL 16816395 T PL16816395 T PL 16816395T PL 16816395 T PL16816395 T PL 16816395T PL 3548001 T3 PL3548001 T3 PL 3548001T3
Authority
PL
Poland
Prior art keywords
drotaverine
diosmin
nanoparticles
manufacturing
solution
Prior art date
Application number
PL16816395T
Other languages
English (en)
Inventor
Marcin BANACH
Jolanta Pulit-Prociak
Original Assignee
Dukebox Sp. Z O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dukebox Sp. Z O.O. filed Critical Dukebox Sp. Z O.O.
Publication of PL3548001T3 publication Critical patent/PL3548001T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
PL16816395T 2016-11-30 2016-11-30 Sposób wytwarzania roztworu nanocząstek kwasu acetylosalicylowego albo diosminy albo drotaweryny PL3548001T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16816395.4A EP3548001B1 (en) 2016-11-30 2016-11-30 A method of manufacturing a solution of nanoparticles of acetylsalicylic acid or diosmin or drotaverine
PCT/IB2016/057230 WO2018100413A1 (en) 2016-11-30 2016-11-30 A method of manufacturing a solution of nanoparticles of acetylsalicylic acid or diosmin or drotaverine

Publications (1)

Publication Number Publication Date
PL3548001T3 true PL3548001T3 (pl) 2022-07-11

Family

ID=57590738

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16816395T PL3548001T3 (pl) 2016-11-30 2016-11-30 Sposób wytwarzania roztworu nanocząstek kwasu acetylosalicylowego albo diosminy albo drotaweryny

Country Status (4)

Country Link
EP (1) EP3548001B1 (pl)
ES (1) ES2918976T3 (pl)
PL (1) PL3548001T3 (pl)
WO (1) WO2018100413A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024023785A1 (en) * 2022-07-29 2024-02-01 Berlia Sushma Paul A stable pharmaceutical oral liquid formulation of an antispasmodic agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US7993749B2 (en) 2005-12-16 2011-08-09 University Of Kansas Nanoparticles comprising a nanoparticle template and a polymer shell having an amide side chain, and method of making thereof
BRPI1002601E2 (pt) * 2010-06-01 2020-06-30 Embrapa Pesquisa Agropecuaria composição nanoestruturada de uso veterinário para administração de fármacos
WO2012059936A1 (en) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Pharmaceutical compositions for colloidal drug delivery
EP2540287A1 (en) * 2011-07-01 2013-01-02 FutureChemistry Continuous flow production of gelatin nanoparticles

Also Published As

Publication number Publication date
WO2018100413A1 (en) 2018-06-07
EP3548001A1 (en) 2019-10-09
EP3548001B1 (en) 2022-04-13
ES2918976T3 (es) 2022-07-21

Similar Documents

Publication Publication Date Title
HK1249496A1 (zh) 用於丙烯酸及其前體的生產系統/生產方法
HK1245762A1 (zh) 丙烯酸生產方法
IL248207A0 (en) Method and system for the automatic production of electronic vapor production devices
GB201609027D0 (en) Waveguide manufacturing method
GB201609026D0 (en) Waveguide manufacturing method
SG11201707623QA (en) Method of producing acetic acid
GB201505178D0 (en) Production of fatty acid estolides
ZA201901641B (en) Process for the production of glycolic acid
GB201716774D0 (en) Method of manufacturing fluorescent-material-containing member
HK1246325A1 (zh) 產生促性腺激素的方法
HUE061332T2 (hu) Eljárás aminobenzoesav vagy aminobenzoesav-származék elõállítására
PL3411350T3 (pl) Sposób produkcji wysokiej czystości kwasu monochlorooctowego
LT3386947T (lt) N-retinoilaminoalkano sulfonrūgšties gamybos būdas
RS60922B1 (sr) Postupci za proizvodnju sirćetne kiseline
GB2548706B (en) Method of manufacturing fluorescent-material-containing member
PL3322688T3 (pl) Sposób wytwarzania kwasu bursztynowego
EP3219805A4 (en) Method for manufacturing cis-5-hydroxy-l-pipecolic acid
PL3548001T3 (pl) Sposób wytwarzania roztworu nanocząstek kwasu acetylosalicylowego albo diosminy albo drotaweryny
GB2510609B (en) Method of manufacturing a beam
SG10201914018UA (en) Process of omega-hydroxyl fatty acid production
RS60748B1 (sr) Procesi za proizvodnju sirćetne kiseline
GB201518266D0 (en) Method for manufacturing continuous wire
PL2977373T3 (pl) Sposób katalitycznego wytwarzania estrów
RS59401B1 (sr) Postupci proizvodnje sirćetne kiseline
ZA201801004B (en) A process and apparatus for manufacturing sugar acid